Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals

被引:183
|
作者
Sedighi, Mansour [1 ]
Razavi, Shabnam [1 ,2 ]
Navab-Moghadam, Fatemeh [1 ]
Khamseh, Mohammad E. [3 ]
Alaei-Shahmiri, Fariba [4 ]
Mehrtash, Amirhosein [5 ]
Amirmozafari, Nour [1 ,2 ]
机构
[1] Iran Univ Med Sci, Sch Med, Dept Microbiol, Tehran 1439914153, Iran
[2] Iran Univ Med Sci, Microbial Biotechnol Res Ctr, Tehran, Iran
[3] Iran Univ Med Sci, Inst Endocrinol & Metab, Endocrine Res Ctr, Tehran, Iran
[4] Iran Univ Med Sci, Inst Endocrinol & Metab, Res Ctr Prevent Cardiovasc Dis, Tehran, Iran
[5] Pasteur Inst Iran, Biotechnol Res Ctr, Mol Med Dept, Tehran, Iran
关键词
Gut microbiota; Bacterial compositions; Type 2 diabetes mellitus; Metabolic syndrome; Real-time PCR; INTESTINAL MICROBIOTA; INSULIN-RESISTANCE; OBESITY; INFLAMMATION; BACTERIA; ASSOCIATION; RELIABILITY; METABOLISM; IMPACTS; ENERGY;
D O I
10.1016/j.micpath.2017.08.038
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recent studies indicate that inflammatory reactions leading to the development of type 2 diabetes mellitus (T2DM) may also contribute to variations in the composition of the intestinal microbiota, suggesting a relation between T2DM and bacterial residents in the intestinal tract. This case-control study was designed to evaluate the composition of the gut microbiota dominant bacterial groups in patients with T2DM compared to the healthy people. A total of 36 adult subjects (18 patients diagnosed with T2DM and 18 healthy persons) were included in the study. The intestinal microbiota composition was investigated by quantitative real-time polymerase chain reaction (qPCR) method using bacterial 16S rRNA gene. The quantities of two groups of bacteria were meaningfully different among T2DM patients and healthy individuals. While, the level of Lactobacillus was significantly higher in the patients with T2DM (P value < 0.001), Bifidobacterium was significantly more frequent in the healthy people (P value < 0.001). The quantities of Prevotella (P value = 0.0.08) and Fusobacterium (P value = 0.99) genera in faecal samples were not significantly different between the two groups. The significant alterations in dominant faecal bacterial genera found in T2DM patients participating in the current study highlight the link between T2DM disease and compositional variation in intestinal flora. These findings may be valuable for developing approaches to control T2DM by modifying the gut microbiota. More investigations with focus on various taxonomic levels (family, genus and species) of bacteria are necessary to clarify the exact relevance of changes in the gut microbial communities with the progression of T2DM disorder. (C) 2017 Published by Elsevier Ltd.
引用
收藏
页码:362 / 369
页数:8
相关论文
共 50 条
  • [41] The effect of metformin combined with liraglutide on gut microbiota of Chinese patients with type 2 diabetes
    Niu, Xiaohong
    Lu, Panpan
    Huang, Linqing
    Sun, Yan
    Jin, Miaomiao
    Liu, Jing
    Li, Xing
    INTERNATIONAL MICROBIOLOGY, 2024, 27 (01) : 265 - 276
  • [42] Compositional differences between gut microbiota of adult patients with asthma and healthy controls
    Hoffmann, Arkadiusz
    Strozik, Tadeusz
    Wasiak, Tomasz
    Buczylko, Krzysztof
    Pawliczak, Rafaal
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (01): : 142 - 149
  • [43] Pharmacologic and Nonpharmacologic Therapies for the Gut Microbiota in Type 2 Diabetes
    Caesar, Robert
    CANADIAN JOURNAL OF DIABETES, 2019, 43 (03) : 224 - 231
  • [44] Beyond gut microbiota: understanding obesity and type 2 diabetes
    Eva Lau
    Davide Carvalho
    Cidália Pina-Vaz
    José-Adelino Barbosa
    Paula Freitas
    Hormones, 2015, 14 : 358 - 369
  • [45] Gut microbiota is a factor of risk for obesity and type 2 diabetes
    Demidova, T. Y.
    Lobanova, K. G.
    Oinotkinova, O. S.
    TERAPEVTICHESKII ARKHIV, 2020, 92 (10): : 97 - 104
  • [46] Response of gut microbiota in type 2 diabetes to hypoglycemic agents
    Zhang, Fanghua
    Wang, Meng
    Yang, Junjie
    Xu, Qian
    Liang, Cheng
    Chen, Bin
    Zhang, Jiaming
    Yang, Ying
    Wang, Huiling
    Shang, Yongfang
    Wang, Ye
    Mu, Xiaofeng
    Zhu, Dequan
    Zhang, Chunling
    Yao, Minxiu
    Zhang, Lei
    ENDOCRINE, 2019, 66 (03) : 485 - 493
  • [47] Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?
    Sircana, Antonio
    Framarin, Luciana
    Leone, Nicola
    Berrutti, Mara
    Castellino, Francesca
    Parente, Renato
    De Michieli, Franco
    Paschetta, Elena
    Musso, Giovanni
    CURRENT DIABETES REPORTS, 2018, 18 (10)
  • [48] Gut microbiota and immunopathogenesis of diabetes mellitus type 1 and 2
    Wang, Fei
    Zhang, Chunfang
    Zeng, Qiang
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2016, 21 : 900 - 906
  • [49] Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus
    Zhou, Zheng
    Sun, Bao
    Yu, Dongsheng
    Zhu, Chunsheng
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [50] Dysbiosis and Regulation of Gut Microbiota in Type 2 Diabetes Mellitus
    Minakshi, Hemlata
    Kumari, Hemlata
    Prakash, Shaurya
    Kumar, Antresh
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2024,